CSPC Pharmaceutical Group Ltd ($1093) - buy or sell? Stock discussion, ideas, forum

CSPC Pharmaceutical Group Ltd

CSPC Pharmaceutical Group Limited, through its subsidiaries, manufactures and sells pharmaceutical products.

Industry: Pharmaceuticals

Ticker	Exchange	ISIN	Name
$1093	HKEx Main Board	HK1093012172	Code: 1093

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 1093 stock

Share your investment idea or question on CSPC Pharmaceutical Group Ltd stock:

Latest twits on CSPC Pharmaceutical Group Ltd (1093)

No twits yet. Be the first to post!

Have a question about 1093? Ask and other investors will be eager to help you.

Have an idea about 1093? Share it with other investors.

CSPC Pharmaceutical Group Ltd news

20/03/2017 CSPC Pharmaceutical Group Ltd reports 26.2% Net Income growth and 1.9 pp EBITDA Margin growth from 24.3% to 26.1%

21/03/2016 CSPC Pharmaceutical Group Ltd Net Income surged on 31.3% in 2015 and Revenue increased on 4.0%

CSPC Pharmaceutical Group Ltd stock price chart

CSPC Pharmaceutical Group Ltd financials

mln. HKD	FY2010	FY2011	FY2012

Revenue	7,774	2,407	4,146
EBITDA	1,589	505.0	945.5
Net income	751.7	355.4	2,162
CAPEX	790.6	322.6	204.2
Debt	1,530	345.7	2,316
Cash	1,100	310.4	1,450

CSPC Pharmaceutical Group Ltd news

About CSPC Pharmaceutical Group Ltd

CSPC Pharmaceutical Group Limited, through its subsidiaries, manufactures and sells pharmaceutical products. The Company's products include vitamin C, antibiotics and common generic drugs. The Company is also engages in the development of innovative drugs and antibiotics.